Efficacy of the treatment with interferon, ribavirin and amantadine, in patients with hepatitis C non-responders or relapsers to the conventional therapy.

被引：0
作者：
Carmen, SE [1 ]
机构：
[1] Hosp Puerta Hierro, Madrid, Spain
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1701
引用
收藏
页码：588A / 588A
页数：1
相关论文
共 50 条
[31]   Interferon-gamma with interferon-alpha and ribavirin for hepatitis C non-responders [J].
Raza, S. ;
Abbas, Z. ;
Jafri, W. ;
Hameed, S. .
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 :44-44
[32]   Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy:: a randomized trial [J].
Salmeron, J. ;
Diago, M. ;
Andrade, R. ;
Perez, R. ;
Sola, R. ;
Romero, M. ;
de la Mata, M. ;
Granados, R. ;
Ruiz-Extremera, A. ;
Munoz de Rueda, P. .
JOURNAL OF VIRAL HEPATITIS, 2007, 14 (02) :89-95
[33]   High-dose interferon alfacon-1 is a treatment option for non-responders and relapsers to combined therapy with interferon and ribavirin. [J].
Sjogren, MH ;
Wu, G ;
Herrine, SK ;
Raufman, JP ;
Bacon, BR ;
Epstein, M ;
Medoff, J ;
Chen, S ;
Waters, B ;
Krawitt, E ;
Sjogren, RW ;
Herrera, J .
HEPATOLOGY, 2000, 32 (04) :352A-352A
[34]   Efficacy of pegylated interferon alpha-2b in combination with ribavirin in patients with chronic hepatitis C non-responders to a previous treatment [J].
Chousterman, M ;
Auray-Cartier, V ;
Hagege, H ;
Arpurt, JP ;
Cassan, P ;
Denis, J ;
Gargot, D ;
Nalet, B ;
Nouel, O ;
Pariente, A ;
Wartelle-Bladou, C .
JOURNAL OF HEPATOLOGY, 2003, 38 :133-134
[35]   Retreatment of chronic hepatitis C in previous non-responders and relapsers [J].
Satoskar, Rohit ;
Jensen, Donald M. .
EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (15) :2491-2503
[36]   Tolerance to pegylated interferon maintenance therapy in patients with chronic hepatitis C who are non-responders to standard combination therapy. [J].
Selim, K ;
Behling, C ;
Lyche, KD ;
Winston, DH ;
Rossi, SJ ;
Wahlstrom, EH ;
Hyun, CB ;
Jensen, JE ;
Babich, MM ;
Nguyen, TT ;
Stewart, MA ;
Myers, WY ;
Ziegler, EA ;
Oliver, DL ;
Hassanein, TI .
HEPATOLOGY, 2002, 36 (04) :574A-574A
[37]   Efficacy of interferon plus ribavirin in chronic hepatitis C patients non responders to interferon alone [J].
Picciotto, A ;
Campo, N ;
Torre, F ;
Brizzolara, R ;
Sinelli, N ;
Celle, G .
HEPATOLOGY, 1998, 28 (04) :479A-479A
[38]   Early Virological Response with Consensus Interferon and Ribavirin in HCV Genotype 3 Non-Responders and Relapsers to Pegylated Interferon Based Therapy [J].
Shakir, Tanzila ;
Abbas, Zaigham ;
Memon, Sadik ;
Tayyab, Ghias ;
Shaikh, Kashif ;
Nasir, Bilal ;
Hassan, Ghias ;
Subhan, Amna ;
Hamid, Saeed .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 :S122-S123
[39]   A controlled study of amantadine monotherapy vs. amantadine combined with interferon-α in chronic hepatitis C patients non-responders to interferon-α. [J].
El-Zayadi, A ;
Selim, O ;
Shawky, S ;
Moustafa, H ;
El-Taweel, A .
HEPATOLOGY, 1998, 28 (04) :473A-473A
[40]   Combination of interferon induction therapy and ribavirin in primary interferon non-responders infected with genotype 1 hepatitis C virus [J].
Erdem, L ;
Akbayir, N ;
Cakaloglu, Y ;
Cevikbas, U ;
Badur, S .
JOURNAL OF HEPATOLOGY, 2002, 36 :234-234
12345